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Short-Chain Carboxylic Acids, A New Class
of Teratogens: Studies of Potential
Biochemical Mechanisms
by Mary E. Coakley,* Sally J. Rawlings,*t and Nigel A.
Brown**
Certain short-chain carboxylic acids (SCCA) appear to share a common teratogenic potential, although
the structural requirements for activity remain obscure. By using a whole rat embryo culture model
system, several biochemical processes have been examined, either as potential initial sites of teratogenic
action or as early steps in the pathway to malformation. Valproate, methoxyacetate, and butyrate were
the prototype SCCA examined. Measurement of [14C]glucose utilization and lactate production confirmed
that energy production by the early organogenesis embryo is predominantly from glycolysis. While the
positive control agent, iodoacetate, caused a significant inhibition of lactate production, none of the SCCA
affected this process or glucose utilization at teratogenic concentrations. Valproate did not influence
embryonic acetyl CoA levels, in marked contrast to the reported response of adult liver, the other major
target of valproate toxicity. Pinocytosis by the visceral yolk sac (VYS) was measured by the uptake of
[125I]polyvinylpyrrolidone. This process ultimately supplies the embryo with amino-acids and is essential
for normal development. SCCA induce morphological abnormalities of the VYS in embryo culture. Pinocy-
tosis was slightly reduced by valproate, but not the other SCCA. However, comparison with the action of
an antiserum, for which inhibition of pinocytosis is the initial teratogenic insult, suggests that this is not
the mechanism for valproate. Incorporation of [3H]thymidine into embryo or yolk sac was not affected
after 3 hr of SCCA exposure, but there was a marked effect of the positive control, hydroxyurea. This
suggests that DNA synthesis is not directly influenced by SCCA. It can be concluded that SCCA do not
exert their teratogenic effects by actions on glycolysis; maintenance of cellular acetyl CoA; pinocytosis
or DNA synthesis. These observations contrast with preliminary results which suggest significant effects
of SCCA on embryonic and yolk sac lipid metabolic pathways.
Introduction
A series of observations from experiments in vivo
and in vitro suggest that short-chain carboxylic acids
(SCCA) share a common property of teratogenic poten-
tial and may represent a new class of teratogens of
human significance. The anticonvulsant drug valproic
acid (Depakene, Epilim) is a simple SCCA of systematic
name 2-propylpentanoic acid and is teratogenic in sev-
eral laboratory species (1-3) and probably also in the
human (4,5). Methoxyacetic acid is the major metabolite
of the glycol ether, 2-methoxyethanol (ethylene glycol
monomethyl ether) (6). We have shown that the tera-
togenic effect of2-methoxyethanol in the rat is probably
mediated by this alkoxy-SCCA metabolite (7). Metab-
olism appears to occur in the maternal, but not the
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embryonic, compartment since direct exposure of iso-
lated rat embryos to the glycol ether is without effect,
while the acid is dysmorphogenic (8).
Using a whole embryo culture model system, we have
studied the potential teratogenicity of about 30 SCCA
and related compounds (2,8-10 and unpublished obser-
vations). Many SCCA induce a similar spectrum of
structural abnormalities in embryo culture, although
potency varies over two orders of magnitude. Of all
SCCA tested to date, butyrate is the most potent, al-
though this compound would not be expected to pose a
major hazard in vivo because of rapid clearance. Note-
worthy aspects of the structure-activity relationships
(SAR) in vitro include: an absolute requirement for a
free carboxyl group; a reduction in potency with any
substitution of C in the alkyl chain (e.g., N, S, or 0);
maximum activity at overall alkyl chain lengths of 4 or
5. So far, this SAR has resisted any mechanistic expla-
nation, and there are no simple relationships with lipid
solubility, pKa or any known pharmacological or bio-
chemical activities.
There have been no direct comparisons of the tera-
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togenic activities of several SCCA in vivo. However,
reported malformation profiles are broadly similar,
which is in general support of the proposal that SCCA
share common activities and, perhaps, common mech-
anisms of action. In the mouse, treatment in early or-
ganogenesis with valproate (2), valproate analogs (Nau,
personal communication) or 2-methoxyethanol (11) in-
duces exencephaly and abnormalities of the axial skel-
eton, while later treatment can cause limb defects. In
the rat, defects of the axial skeleton predominate
(1,3,7). It is interesting that most of these malforma-
tions are "general," that is to say, commonly induced
by many treatments, including maternal toxicity
(12,13). There is little doubt, however, that at least
some SCCA have effects on the embryo in vivo at sig-
nificantly lower doses than those which induce overt
maternal toxicity. In other words, these compounds are
"teratogenic hazards" (2,11,14).
The aims of current studies are to identify the em-
bryonic site(s) of biochemical action of SCCA and to
characterize the initial biochemical response(s). The em-
bryo culture model system has been used for two main
reasons. The exposure conditions required for SCCA to
induce structural defects consistently are well estab-
lished in this laboratory. In addition, the use of radi-
otracers and other biochemical manipulations are facil-
itated, compared to the whole animal. We report here
the potential actions of three prototype SCCA-val-
proate, methoxyacetate, and butyrate-on four pro-
cesses: glycolysis, maintenance of cellular acetyl CoA
levels, pinocytosis, and DNA synthesis.
Glycolysis is the major source of energy in the rodent
organogenesis embryo (15) and disruption of this pro-
cess can lead to so-called "fuel-mediated" teratogenesis
(16). In addition, it has been suggested that methoxy-
acetate exerts its testicular toxicity by interference
with lactate production and utilization in Sertoli cells
(17,18). In adult liver, valproate profoundly affects cel-
lular acetyl CoA levels leading to various biochemical
derangements and, ultimately, hepatotoxicity (19,20).
[Some of our studies on embryonic acetyl CoA and val-
proate have been published (21)]. Pinocytosis by the
visceral yolk sac was examined because it is essential
for normal development and the yolk sac is morphol-
ogically affected by SCCA (2,8,10). Finally, potential
actions on DNA synthesis were examined because
SCCA are growth retarding and appear to be capable
of affecting most organs of the conceptus. Normal DNA




All the studies reported here used explanted whole
conceptuses (i.e., embryo, amnion, visceral yolk sac,
and placenta) maintained in vitro, as follows. LAC-P
rats were mated overnight; those females with plugs
the following morning were considered to be in the first
day of gestation. Embryonic ages used throughout this
report were calculated from zero time as the mid-point
of the mating period. The whole embryo culture tech-
niques used have been described in detail elsewhere
(22). In brief, standard 9.5-day 48-hr cultures were per-
formed as follows. Conceptuses were explanted on day
10 of gestation. Two or three conceptuses were cultured
in 50-mL Soveril bottles containing 4 mL of standard
medium, comprising 75% immediately centrifuged,
heat-inactivated rat serum and 25% Eagle's Minimal
Essential Medium with Earle's salts (MEM). Bottles
were rotated at 30 rpm and incubated at 37°C for 48 hr.
The initial gas phase was 5% 02, 5% Co2, 90% N2. The
oxygen content was increased to 20% at 16 hr and 40%
at 26 hr (5% CO2 at all times). Where SCCA were added,
the acid was neutralized by dissolving in an equimolar
volume of 1 N NaOH, followed by dilution to volume
with MEM to form a neutral stock solution in MEM.
Throughout the studies, measurement of total protein
content was by the method of Lowry.
Glycolysis
After 16 hr of standard culture, three or four con-
ceptuses were transferred into 53 x 15mm plastic tubes
(minivials, Gordon-Keeble) containing 1 mL standard
medium including 1.1 ,uCi [U-14C]glucose (270 mCi/
mmole, Amersham). The mean glucose concentration of
batches of rat serum was 1.5 mg/mL, as determined by
a glucose oxidase colorimetric assay (Sigma). MEM con-
tains 1 mg/mL glucose, giving a final medium specific
activity for glucose of 0.144 mCi/mmole. Conceptuses
were incubated for 8 hr, with or without treatment, at
37°C with 20% 02 and rolling at 60 rpm. Conceptuses
grew well under these conditions, with active heart beat
and yolk sac circulation throughout. At the end of in-
cubation, 10 ,uL samples of medium were taken for de-
scending paper chromatography with butanol/water/
acetic acid (4:5:1) as solvent, in order to separate glucose
from metabolites. Paper was cut into strips that were
counted for radioactivity. The Rf values for glucose and
lactate were determined from standards.
Acetyl CoA
Two experimental designs were used. (1) After 16 hr
of standard culture, valproate was added to the medium
to a concentration of 1.5 mM and cultures were contin-
ued for 8 hr. Conceptuses were then harvested, washed,
snap-frozen in liquid N2 and stored overnight at - 70°C.
(2) After 40 hr of standard culture, valproate was added,
as above, and cultures continued for 4 hr. During this
period, conceptuses were taken each hour for immediate
analysis. Acetyl CoA was determined by the citrate
synthase method of Pande and Caramancion (23). The
assay method was as described, but tissue preparation
was scaled down so that single 11.3-day (40-44 hr) em-
bryos or yolk sacs, or three 10.5-day (24 hour) concep-
tuses could be assayed.
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Pinocytosis
The method for measuring fluid-phase pinocytosis by
visceral yolk sacs was essentially that of Williams et al.
(24), as we have described in detail elsewhere (25).
Briefly, 11.3-day conceptuses were cultured individually
in minivials containing 1 mL of 25% rat serum, 75%
MEM including 1.0 ,uCi [125I]polyvinyl-pyrollidone
(PVP). After 4 hr incubation, with or without treat-
ment, at 37°C, 40% 02, and rolling at 60 rpm, yolk sacs
were isolated, washed, homogenized, contained radio-
activity counted and protein content measured. Pino-
cytosis is expressed as a clearance, in units of microli-
ters ofmedium whose contained radioactivity was taken
up per milligram yolk-sac protein per hour (2.').
DNA Synthesis
Thymidine incorporation was measured over two ex-
posure periods. Following 16 hr standard culture,
SCCA was added to the medium. After 2 hr ofexposure,
3 ,uCi/mL [3H-methyl]thymidine (25 Ci/mmole) was
added, and incorporation allowed to proceed for an ad-
ditional 1 or 2 hr. Alternatively, 11.3-day coneeptuses
were cultured in minivials in 1 mL standard medium.
Following a 1-hr pre-equilibration, SCCA was added,
and experiments proceeded as above. Preliminary ob-
servations showed that incorporation of activity into
acid-insoluble fractions of embryo and yolk sac was lin-
ear over 2 hr. At the end of incubation, embryos and
yolk sacs were isolated, washed, homogenized, and a
sample taken for DNA determination (26). Protein car-
rier (serum) was added and samples were TCA precip-
itated, centrifuged, the soluble fraction taken for count-




The amount of ['4C]glucose utilized and lactate pro-
duced by 10.5-day conceptuses is shown in Table 1.
Overall, conceptuses utilized about 900 pmole glucose/
i'g protein/hr and produced from it about 1500 pmole
lactate/,Lg protein/hr, which is greater than 80% con-
version. This conversion is consistent with previous
data concerning mouse and rat embryos (15,27) and the
rate of lactate production is very similar to published
data on rat embryos at this stage (27). Exposure of
conceptuses to the positive control compound, iodoac-
etate, which inhibits glycolysis at the glyceraldehyde
phosphate dehydrogenase step, resulted in a 90% in-
hibition of lactate production (Table 1). Concentrations
of iodoacetate as low as 3 1xM significantly reduced lac-
tate production (data not shown). Valproate, butyrate,
and methoxyacetate had no significant effect on glucose
utilization or lactate production, nor on total protein
content (Table 1).
Table 1. Glucose utilization and lactate production by 10.5-day
rat conceptuses in vitro during an 8-hr exposure to carboxylic
acids.
Glucose Lactate
utilized, produced, Protein, Number of
Treatment pmole/,ug/hra pmole/p.g/hra pu/conceptusa samples
Control 928 ± 47 1508 ± 46 119 ± 4 12
Valproate 797 + 56 1417 ± 62 103 ± 2 6
(1.5 mM)
Butyrate 1049 ± 149 1656 ± 69 114 ±2 6
(0.75 mM)
Control 863 87 1365 ±52 119 ± 6 6
Methoxyacetate 827 ± 111 1255 ± 31 116 ± 6 6
(5.0 mM)
Iodoacetate 867 + 63 183 ± 14** 64 ± 7** 3
(0.1 mM)
a Data as X ± SE. Each sample was three or four conceptuses.
** Significantly different from control, p < 0.01, ANOVA.
Acetyl CoA
The acetyl CoA content of 10.5-day conceptuses is
shown in Table 2. These values were measured after
samples had been frozen and stored overnight. We have
found that recovery of acetyl CoA is about 40% efficient
by this procedure, compared to 95% for unfrozen, un-
stored samples. Freezing of the e samples was neces-
sary because conceptuses were removed from culture
in the late afternoon, and the acetyl CoA assay requires
a full working day. There was no significant effect of an
8-hr exposure to 1.5 mM valproate on acetyl CoA levels
(Table 2). Total protein content of conceptuses was also
not affected by valproate. Protein values in these ex-
periments are lower than those shown in Table 1 be-
cause conceptuses were TCA precipitated, and the pel-
let washed and redissolved prior to protein
determination.
As described for the younger conceptuses, there was
also no effect of 1.5 mM valproate on acetyl CoA levels
in 11.3-day embryos or yolk sacs exposed for 4 hr (Fig.
1). The acetyl CoA level was about 100 pmole/mg pro-
tein in these freshly analyzed tissues, which is compa-
rable to adult liver (23). The level in 10.5-day concep-
tuses is also of this order, the lower values shown in
Table 2 being due to loss during freezing and storage,
as described.
Pinocytosis
Uptake of [1211]PVP was measured as an index of
fluid-phase pinocytosis by the visceral yolk sac of 11.3-
Table 2. Acetyl CoA content of 10.5-day rat conceptuses after 8
hr exposure to valproate in vitro.
Acetyl CoA, pmole/ Protein, pig/
Treatment mg proteina conceptusa
Control 41.5 ± 6.0 84.5 ± 5.0
Valproate (1.5 mM) 46.3 ± 6.0 92.4 ± 3.1
aData as X ± SE, four samples, three conceptuses each. No sig-
nificant differences between treatment and control, Student's t test,
p > 0.2.
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EMBRYO (T± SEM) YOLK SAC (± SEM) variance, three significant treatment-related differ-
ences were detected. Incorporation into the acid-insol-
JWz4 Ee} 5 4 T48 51 I4 uble fraction of yolk sacs was slightly increased by both
30 -- ------I butyrate (2 mM) and valproate (5 mM), whereas soluble
(8) W YW (4 (5) counts were increased in yolk sacs exposed to 20 mM
50. methoxyacetate (Table 4).
1.5 mM ValProate A----= 1.5mM Valoroate [3H]Thymidine incorporation was also measured us-0-0 Control o-o Control ing 10.5-day conceptuses in an identical protocol (data
o- . . . . . . . .6not shown). Again, SCCA exposure had little influence,0 1 2 34 0 1 2 3 4 excepting a significant increase in acid-insoluble counts
Time after treatment (hr) in methoxyacetate (20 mM)-treated yolk sacs at 2 hr
E 1. Acetyl CoA content of 11.3-day rat conceptuses in vitro (data not shown). None of the data, at either embryonic
ring a 4-hr exposure to 1.5 mM valproate. There are no signif- age, give any indication of an inhibition of[3H]thymidine
nt time or treatment-related effects (analysis of variance). incorporation caused by SCCA.
In contrast to the lack of effect shown by SCCA, the
positive control compound, hydroxyurea (2.5 mM), in-
'onceptuses. Four series of experiments are sum- duced marked changes. Counts in the soluble fractions
red in Table 3. Uptake was slightly, but signifi- of 11.3-day conceptuses were increased to 209% and
y, reduced by 5 mM valproate exposure, and there 170% of control for embryos and yolk sacs, respectivelysmall, insignifcant recductions with 5 mMe butyrateA n (Table 4). Acid-insoluble counts were reduced to about
m..0mM methoxyacetate. Lower concentrations of 2% of control for both embryos and yolk sacs (Table 4).
nLiA l wiarin wi 1iJtfL Jffcor. Th1 nJ.Jifiuc rntJLUtWi>l ak;lu WU1t;1 WIl'llUUb U11VUL. 11 fc puolUlC uUllLrul
treatment, an antivisceral yolk-sac endoderm anti-
serum, induced significant reductions of uptake at both
doses tested (Table 3). In each series, total yolk-sac
protein content did not vary between treatment and
control groups (data not shown).
DNA Synthesis
The incorporation of [3H]thymidine into acid-soluble
and -insoluble fractions of 11.3-day conceptuses is shown
in Table 4. Although incorporation (on the basis of DPM/
,ug DNA) into both fractions was greater for yolk sac
than embryo, fractional incorporation (insoluble/total)
was identical for the two tissues over 1- and 2-hr thy-
midine exposures (data not shown). Overall, SCCA ex-
posure had little influence on incorporation. Table 4
shows data obtained after 1 hr thymidine, but similar
results were collected at 2 hr. From the analysis of
Table 3. Pinocytosis of 125I-PVP by the visceral yolk sac of 11.5-
day rat conceptuses in vitro during a 4-hr exposure to carboxylic
acids.
Fluid pinocytosed
Treatment Concn ,LL/mg yolk sac protein/hr'
Control 2.25 ±0.05 (n = 6)
Valproate 2 mM 2.00 ± 0.20 (n = 4)
5 mM 1.85 ± 0.09* (n = 6)
Control 2.08 ± 0.10 (n = 6)
Butyrate 2 mM 2.31 ± 0.40 (n = 3)
5 mM 1.76 ± 0.18 (n = 7)
Control 1.51 ± 0.20 (n = 5)
Methoxyacetate 10 mM 1.59 ± 0.07 (n = 6)
20mM 1.48±0.14 (n = 5)
Control 2.01 ± 0.09 (n = 12)
Antiserum 10 ,uL/mL 1.61 ± 0.08t (n = 9)
50 ,uL/mL 0.88 ± 0.10t (n = 4)
'Values as X + SE (n = number of conceptuses).




The rationale for performing these experiments using
the in vitro whole embryo culture model was that both
exposure and response are more reproducible in this
system, compared to in utero, and that radiotracer stud-
ies are greatly facilitated. It is important, however, to
ensure that the model accurately reflects teratogenesis
in vivo. In other studies, we have shown that manip-
ulation of concentration and timing of exposure to val-
proate in vitro enables the production of embryos with
abnormalities of widely differing severity and mor-
phology (2,28). Almost all embryos exposed to 1.5 mM
valproate from 16 to 24 hr of standard culture and ex-
amined at 48 hr show abnormalities in mesoderm seg-
mentation manifest as somite defects. These defects are
apparently identical to those of 11.5-day embryos in vivo
following valproate treatment on gestation day 11 (28).
These embryos, both in vivo and in vitro, are relatively
subtly affected, and we have observed that embryos
that are more grossly abnormal at this stage in vivo do
not survive to term. In designing biochemical studies
of teratogenesis, it is important to avoid measurements
on grossly defective embryos, which may have artifac-
tual biochemical abnormalities.
Another major problem in biochemical studies of ter-
atogenesis is the timing of measurements in relation to
exposure so that observed effects are restricted to initial
insults, or early events in the sequence leading to mal-
formation. The majority of the studies described here
utilized the experimental design described above, with
exposure to SCCA from 16 to 24 hr of culture. Mea-
surements were made during, or at the end of, this
period, since it is clear that the teratogenic insult has
been delivered by 24 hr and is not reversed by returning
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Table 4. Incorporation of [3H]-thymidine by 11.3 day rat conceptuses in vitro during the final hour of a 3-hr exposure to carboxylic
acids.
DPM x 10-34Lg DNA
Soluble Insoluble DNA (Qg)
E YS E YS E YS
Control (n= 11) 1.1 ± 0.3 2.2 ± 0.7 3.1 ± 0.6 6.5 ± 1.2 24 ± 5 5.2 ± 1.0
Butyrate, 2 mM 1.1 ± 0.3 2.4 ± 0.5 3.0 ± 0.7 7.3 ± 2.1* 21 ± 7 4.6 ± 1.2
Control (n = 4) 0.9 ± 0.2 1.4 ± 0.1 3.0 ±0.9 5.2 ± 0.3 24 ± 4 6.2 ± 1.0
Valproate, 5 mM 0.8 ± 0.2 1.5 ± 0.3 3.2 ± 0.6 6.0 ± 0.6* 22 ± 7 5.8 ± 1.3
Control (n = 4) 0.8 ± 0.1 1.9 ± 0.3 2.3 ± 0.4 5.6 ± 0.4 29 ± 5 6.4 ± 0.9
Methoxyacetate, 20 mM 1.0 ± 0.1 2.4 ± 0.2* 2.5 ± 0.1 5.3 ± 0.1 37 ± 6 8.3 ± 1.2
Control (n =4) 1.1±0.1 2.0±0.1 3.6±0.3 6.7±0.4 28±5 7.0±1.1
Hydroxyurea, 2.5 mM 2.3 ± 0.2t 3.4 ± 0.4t 0.07 ± 0.006t 0.16 ± 0.02t 23 ± 4 6.7 ± 0.6
aData as X ± SD, I t Significance by ANOVA: *p < 0.05, tp < 0.01, tp < 0.001.
that cannot be detected at 24 hr cannot be an early,
"initiating" event.
From studies of different SCCA exposure levels and
times, it is clear that virtually all tissues of the concep-
tus can be rendered morphologically abnormal by SCCA
treatment in vitro. When exposure is manipulated to
result in subtle defects of specific organs, we would
propose that a similar biochemical insult (e.g., enzyme
inhibition) is delivered to most, or all, cells of the con-
ceptus. However, primordia respond differently, de-
pending upon the developmental processes underway
at the time of insult. (The induction of somite defects
suggests that some aspect of mesoderm segmentation
is especially sensitive to the changes induced by SCCA
exposure.) Following this argument leads to the con-
clusion that the whole embryo can be taken for analysis
of biochemical changes, rather than just those tissues
which give rise to defective structures.
Glycolysis
The current data on glucose utilization by early or-
ganogenesis embryos are in agreement with previous
studies of carbohydrate metabolism and energy pro-
duction at this stage, which show that glycolysis is the
major (-90%) pathway (15,27). The observed rate of
lactate production (1300-1500 pmole/ing protein/hr, Ta-
ble 1) is very similar to that in an earlier study of rat
conceptuses in vitro (27) and also to that in a study of
mouse conceptuses, when reported inaccurate calcula-
tions are corrected (29). A second study of the mouse
reports much higher rates, but this is probably due to
differences in protein determinations (15).
None of the three SCCA tested had any effect on
glucose utilization or lactate production (Table 1), in
contrast to the positive control, iodoacetate. It has been
suggested that methoxyacetate exerts its testicular tox-
icity by interfering with lactate production and/or uti-
lization by Sertoli cells (17,18). The structure-activity
relationships for SCCA and teratogenic potency in
whole embryo culture are remarkably similar to those
for SCCA in a Sertoli/germ cell culture model of testic-
ular toxicity (Gray et al., unpublished). Whether or not
the testicular toxicity of SCCA involves effects on gly-
colysis, it seems clear that their teratogenic action does
not.
Acetyl CoA
The major adverse effect of valproate in the adult,
both clinically and in laboratory animals, is hepatotoxic-
ity (30). The exact mechanism of this action is not
known, but it is clear that there are many hepatic bio-
chemical disruptions which can be explained by reduced
concentrations of cellular CoA and derivatives (19,20).
Hepatic valproate treatment in vivo or in vitro results
in a dramatic fall in cellular acetyl CoA levels within 30
min (19,20). The results presented in Table 2 confirm
our previous observations that valproate has no action
on embryonic acetyl CoA (21). This is thought to be due
to the lack of enzymatic conversion of valproate to val-
proyl CoA (21).
In other studies (Rawlings et al., unpublished), we
have found no evidence for embryonic conversion of
methoxyacetate to methoxyacetylglycine-the major
metabolite in the adult (31)-which also proceeds
through an acyl-CoA intermediate. In contrast, buty-
rate is extensively incorporated into acid-insoluble ma-
terial by the yolk sac and embryo (32), suggesting com-
petence at forming the CoA derivative of this natural
SCCA. Since these three SCCA exert similar actions
on the isolated embryo, it seems unlikely that embryonic
metabolism of the compounds has a major role in the
teratogenic action.
Pinocytosis
Treatment of rat or mouse conceptuses in vitro with
SCCA induces morphological abnormalities of the vis-
ceral yolk sac at media concentrations only slightly in
excess of the minimum concentrations that cause em-
bryonic defects (2,10). These VYS abnormalities are
apparent on gross observation and it is likely that more
subtle changes induced by lower concentrations would
be revealed by histological examination. In other stud-
ies we have shown that an anti-VYS endoderm anti-
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serum induces teratogenesis by interfering with VYS
pinocyotic function (25). In whole embryo culture, this
antiserum can induce abnormality of 67% of embryos at
a concentration where only 20% of VYS have any ob-
servable defect (25). Thus, embryonic defects can be
induced by impaired VYS function even when there is
no apparent action on VYS morphology and it was
thought that the SCCA may mediate their effects by a
similar mechanism.
The data in Table 3 show that the SCCA have no
effect on VYS pinocytosis at high teratogenic concen-
trations. There was a signific ,nt reduction induced by
valproate at 5 mM, but this is not thought to be signif-
icant, from the following comparison. The lower con-
centration of positive control antiserum used (10 VtLl
mL) significantly reduced pinocytosis (Table 3). This
concentration induces 67% embryonic abnormality in
9.5-day rat conceptuses exposed for 48 hr, but is not
grossly toxic to the VYS, inducing only 20% defects
(25). In cultures of the same design, 2 mM valproate, 2
mM butyrate, or 10 mM methoxyacetate would induce
grossly abnormal VYS and embryos, but these concen-
trations did not affect VYS pinocytosis (Table 3).
DNA Synthesis
It is widely accepted that agents which interfere with
DNA synthesis or function in the embryo are likely to
be teratogenic (33). At the early organogenesis phase
all embryonic primordia are actively dividing, although
the exact rate varies from organ to organ at any one
time. Because the SCCA are growth-retarding and
seem capable of affecting virtually all tissues of the em-
bryo, under appropriate exposure conditions, DNA syn-
thesis was considered as a potential target because it
is one of the processes common and essential to all tis-
sues.
The design of the experiments was to attempt to mea-
sure an initial action on DNA synthesis (thymidine in-
corporation). Since SCCA, at appropriate concentra-
tions, can induce significant growth retardation in
embryo culture over 24 or 48 hr (2,10), it would un-
doubtedly be possible to measure a reduction in DNA
synthesis over such a time period. However, this is
likely to be a secondary, rather than an initial, response.
Thus, thymidine incorporation was measured during the
third or fourth hours of exposure to teratogenic con-
centrations of SCCA. It is clear from the data shown
in Table 4 that there is no initial inhibition of thymidine
incorporation into acid-insoluble pools by SCCA. There
is an apparent small stimulation of incorporation into
the insoluble fraction of yolk sacs, but this is variable
and of unknown significance. These experiments do not
rule out the possibility of some effect on de novo purine
or pyrimidine synthesis, as has been suggested for the
related compound 3-hydroxybutyric acid (34). It is not
clear whether such an effect would influence thymidine
incorporation via the salvage pathway over the time
scale examined. The response to the positive control
compound, hydroxyurea, does not help to resolve this
issue, as it inhibits DNA synthesis at the ribonucleoside
diphosphate reductase step.
Conclusions
It is thought that the experimental designs used in
these studies minimize the chances of measuring sec-
ondary biochemical changes after teratogen exposure.
In addition, they ensure that embryonic tissues are ex-
amined during realistic exposures to SCCA, which are
known to result in malformation. Therefore, the lack of
effect of SCCA on glycolysis; acetyl CoA; pinocytosis
and thymidine incorporation is not due to insensitive
procedures, but strongly suggests that these processes
are not involved in the early steps of the teratogenic
mechanisms of these compounds. Confidence in this con-
clusion is bolstered by our recent experiments, of sim-
ilar design, in which the effects of SCCA on incorpo-
ration of [3H]acetate into lipid fractions has been
measured (35). Both valproate and butyrate appear to
induce highly significant changes. These changes affect
specific classes of lipids and the responses of the embryo
and the yolk sac appear to differ (35). The significance
of the changes is not yet established, but they do illus-
trate that early biochemical changes can be detected in
this model system. This strengthens the conclusion that
the processes measured in this study are not involved
in the teratogenic mechanism of carboxylic acids.
The authors are grateful for assistance and advice from Drs. S. J.
Freeman and M. Webb, K. Hardy and L.-S. Jin, and to Dr. M. F.
W. Festing for the statistical analyses.
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